Corporate Banner
Satellite Banner
Informatics
Scientific Community
 
Become a Member | Sign in
Home>Products>This Product
  Products


OMIX LIMS Multi-Lab Informatics Platform

Product Image
Product Description

Multi-Lab Informatics Platform for Life Sciences Research

The OMIX research platform from GenoLogics provides a highly configurable life sciences system for cross-science and multiple lab implementations. Today's life sciences research enterprises use more samples in ever more complex experiments, generating growing volumes of data. A robust informatics platform is crucial to improving operational efficiency, and for enhancing data management to publish meaningful results.
The OMIX’s built-in Lab Configuration Engine technology allows you to tailor the platform to fit your lab. You can configure this platform for a wide range of workflows from genomics and proteomics to cell biology, metabolomics, and imaging.

Multi-Lab Informatics Platform: Capabilities

• Tight integration to a wide range of instruments, applications, platforms, workflows and software
• The Automated Informatics framework provides automatic data capture and supports results parsing, contextual data integration and bioinformatics pipelining
• The Adaptive Reporting framework provides interactive reporting capabilities to query data from multiple sources and provide a holistic view of the data
• LabLink's secure Web-based collaboration portal allows you to streamline interactions with customers and researchers and optimize customer service levels

The OMIX platform accurately segments laboratory and project data to facilitate comprehensive implementations across multiple labs and science environments, and provides strong security and data archiving mechanisms to facilitate integrated analytics.

Multi-Lab Informatics Platform: Standards Compliance

The OMIX platform supports the compliance of many government regulations, including 21 CFR Part 11, 21 CFR Part 58 and HIPAA privacy laws.

OMIX is the underlying informatics platform that supports our science-purposed lab and data management solutions for genomics, next generation sequencing and proteomics.

Product OMIX LIMS Multi-Lab Informatics Platform
Company Genologics
Price Request a quote
More Information View company product page
Catalog Number Unspecified
Quantity Unspecified
Company Logo

Genologics
Suite 2302 - 4464 Markham Street, Victoria, British Columbia, Canada, V8Z 7X8



Email: info@genologics.com



Scientific News
Researchers Develop Software That Could Facilitate Drug Development
AptaTRACE can identify aptamers, potentially speed drug advancement.
Protein Nanocages Could Improve Drug Design and Delivery
HHMI scientists have designed and built 10 large protein icosahedra that are similar to viral capsids that carry viral DNA.
Connectome Map More Than Doubles Human Cortex’s Known Regions
Researchers at NIH have developed software that automatically detects the “fingerprint” of each of these areas in an individual’s brain scans.
Virus Inspired Cell Cargo Ships
Virus-inspired container design may lead to cell cargo ships following construction of ten large, two-component, icosahedral protein complexes.
Three-Drug Combinations Counter Antibiotic Resistance
Research shows that combinations of three different antibiotics can treat resistant bacteria, even if they are ineffective independently.
Supercomputing and Drug Discovery
New biotech company uses supercomputer simulations to speed up drug discovery and biotech molecule development.
Identifying Cancer Drug Targets Using 3D-Modelling
Researchers are now able to model genetic mutations manipulation of proteins that can potentially drive cancer.
Human Evolution Driven by Viruses
Study finds surprising percentage of protein adaptions in humans have been driven by viruses.
Earliest Sign of Alzheimer's Development Discovered
Researchers have identified the first physiological signs of late-onset Alzheimer's disease, underlining the importance of computational power in neurology.
Computational Method Offers Significant Boost in Finding New Cancer Targets
MIT and ARIAD Pharmaceuticals team have identified evidence of significant cancer mutations.
Scroll Up
Scroll Down

SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,300+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,900+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!